SCHEMBL13437136

SCHEMBL13437136

Nc1ccccc1NC(=O)c1cccc2c1-c1ccccc1C2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
POLB P06746 3/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
KEAP1 Q14145 2/20 0.56
NFE2L2 Q16236 1/20 0.56
MAPT P10636 2/20 0.55
HTT P42858 1/20 0.55
GAA P10253 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
KDM4E B2RXH2 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
HSD17B10 Q99714 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
HDAC3 O15379 1/20 0.50
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4586925 0.89 MAPT (0.56) ALDH1A1MAPTHTT
SCHEMBL10870706 0.86 MAOA (0.60) ALDH1A1POLBMEN1KMT2AMAPT
SCHEMBL20271919 0.80 MAOA (0.69) ALDH1A1POLBMEN1KMT2AKEAP1
SCHEMBL8399721 0.79 HDAC1 (0.69) ALDH1A1HTTGAANPC1RAB9A
SCHEMBL3560083 0.78 MAPT (0.52) ALDH1A1POLBMEN1KMT2AKEAP1
SCHEMBL392793 0.78 NPC1 (0.70) ALDH1A1HTTGAANPC1RAB9A
SCHEMBL10750834 0.78 CASP3 (0.65) ALDH1A1POLBMEN1KMT2AHTT
SCHEMBL6807417 0.77 KEAP1 (0.54) ALDH1A1POLBMEN1KMT2AKEAP1
Hydrochloric Acid SCHEMBL11743643 0.76 NPC1 (0.68) ALDH1A1HTTGAANPC1RAB9A
SCHEMBL4925144 0.76 HDAC1 (0.56) ALDH1A1KMT2AHTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 ALDH1A1 3050/4885POLB 2202/4885MEN1 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.